Compound Summary
PAPAVERINE HYDROCHLORIDE
Compound Information
PAPAVERINE HYDROCHLORIDE
Compound Name: | PAPAVERINE HYDROCHLORIDE |
Compound CID: | 6084 |
Synonyms: | PAPAVERINE HYDROCHLORIDE 61-25-6 Cardiospan Cardoverina Papaversan More... |
Iupac Name: | 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline;hydrochloride |
InChI: | InChI=1S/C20H21NO4.ClH/c1-22-17-6-5-13(10-18(17)23-2)9-16-15-12-20(25-4)19(24-3)11-14(15)7-8-21-16;/h5-8,10-12H,9H2,1-4H3;1H |
InChIKey: | UOTMYNBWXDUBNX-UHFFFAOYSA-N |
Canonical Smiles: | COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC.Cl |
Isomeric Smiles: | COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC.Cl |
Molecular Weight: | 375.8 |
Molecular Formula: | C20H22ClNO4 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
PAPAVERINE HYDROCHLORIDE
Molecular Weight: | 375.8 |
Molecular Formula: | C20H22ClNO4 |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 5 |
Rotatable Bond Count: | 6 |
Heavy Atom Count: | 26 |
Complexity: | 407 |
Synonyms
PAPAVERINE HYDROCHLORIDE
| PAPAVERINE HYDROCHLORIDE | PAPAVERINE HYDROCHLORIDE |
|---|---|
PAPAVERINE HYDROCHLORIDE |
61-25-6 |
Cardiospan |
Cardoverina |
Papaversan |
Forpavin |
Papalease |
Pavatest |
Pavabid |
Cerespan |
Dispamil |
Drapavel |
Paverolan |
Alapav |
Cerebid |
Delapav |
Dilaves |
Durapav |
Dynovas |
Myobid |
Pameion |
Papacon |
Pavacap |
Pavacen |
Paveron |
Pavnell |
Vasal |
Ro-Papav |
Vaso-Pav |
Papaverinium chloride |
1-(3,4-Dimethoxybenzyl)-6,7-dimethoxyisoquinoline hydrochloride |
Papanerin-hcl |
Papavarine chlorhydrate |
Pap-Kaps-150 |
Papaverine chlorohydrate |
Papaverine, HCl |
PAP H |
Papaverine (hydrochloride) |
Papaverine monohydrochloride |
NCI-C56359 |
Papaverine Hcl |
Chlorhydrate de papaverine |
NSC 35443 |
UNII-23473EC6BQ |
6,7-Dimethoxy-1-veratrylisoquinoline hydrochloride |
MLS000028497 |
23473EC6BQ |
MFCD00012745 |
NSC-35443 |
Artegodan |
Cepaverin |
Optenyl |
Pavagrant |
Pavakey |
Pavased |
SMR000058283 |
Therapav |
Dipav |
Lapav |
DSSTox_CID_5825 |
Spasmo-Nit |
Isoquinoline, 1-((3,4-dimethoxyphenyl)methyl)-6,7-dimethoxy-, hydrochloride |
DSSTox_RID_77939 |
DSSTox_GSID_25825 |
Papanerin-HCl German |
1-(3,4-dimethoxyphenyl)methyl-6,7-dimethoxyisoquinoline;hydrochloride |
NSC35443 |
CCRIS 3804 |
CAS-61-25-6 |
SR-01000003098 |
Chlorhydrate de papaverine French |
NCGC00015810-02 |
EINECS 200-502-1 |
Pamelon |
Qua bid |
Isoquinoline, 1-((3,4-dimethoxyphenyl)methyl)-6,7-dimethoxy-, hydrochloride (1:1) |
Isoquinoline, 1-(3,4-dimethoxyphenyl)methyl-6,7-dimethoxy-, hydrochloride (1:1) |
Prestwick_376 |
Papaverine hydrochloride USP:JAN |
Pavabid (TN) |
component of Copavin |
Isoquinoline, 6,7-dimethoxy-1-veratryl-, hydrochloride |
6,7,3,4-Tetramethoxy-1-benzylisoquinoline hydrochloride |
Papaverine, hydrochloride |
Opera_ID_1617 |
C20H21NO4.HCl |
REGID_for_CID_6084 |
MLS001148655 |
MLS002222208 |
ARONIS23834 |
CHEMBL98123 |
SCHEMBL121268 |
SPECTRUM1500459 |
Papaverine hydrochloride, powder |
DTXSID9025825 |
cas 61-25-6 |
AOB5339 |
HMS1569F08 |
HMS1920F06 |
Pharmakon1600-01500459 |
Tox21_110226 |
Tox21_500957 |
CCG-40065 |
HY-18077A |
NSC757256 |
SBB080541 |
Papaverine hydrochloride (JP17/USP) |
AKOS005111070 |
Tox21_110226_1 |
CS-5015 |
LP00957 |
NSC-757256 |
NCGC00015810-12 |
NCGC00094258-01 |
NCGC00094258-02 |
NCGC00094258-03 |
NCGC00094258-04 |
NCGC00094258-05 |
NCGC00094258-06 |
NCGC00261642-01 |
AS-13262 |
H754 |
ST077145 |
1-(3,7-dimethoxyisoquinoline hydrochloride |
DB-053821 |
EU-0100957 |
P0016 |
D02218 |
D86684 |
P 3510 |
Isoquinoline,7-dimethoxy-1-veratryl-, hydrochloride |
SR-01000003098-2 |
SR-01000003098-4 |
SR-01000003098-9 |
WLN: T66 CNJ B1R CO1 DO1& HO1 IO1 &GH |
Q27253713 |
SR-01000003098-11 |
6,3,4-Tetramethoxy-1-benzylisoquinoline hydrochloride |
1-(3,4-Dimethoxybenzyl)-6,7-dimethoxyisoquinolinehydrochloride |
Isoquinoline, 6,7-dimethoxy-1-veratryl-, hydrochloride (8CI) |
4-(6,7-dimethoxyisoquinolyl)methyl-1,2-dimethoxybenzene, chloride |
Isoquinoline,4-dimethoxyphenyl)methyl-6,7-dimethoxy-, hydrochloride |
Papaverine hydrochloride, British Pharmacopoeia (BP) Reference Standard |
Papaverine hydrochloride, European Pharmacopoeia (EP) Reference Standard |
Papaverine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material |
Papaverine hydrochloride, United States Pharmacopeia (USP) Reference Standard |
Experimental Data
PAPAVERINE HYDROCHLORIDE
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 6.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
PAPAVERINE HYDROCHLORIDE
Statistics Data
PAPAVERINE HYDROCHLORIDE
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 6.000000000000000 | 1 | 1 |
Statistics Data Visualization
PAPAVERINE HYDROCHLORIDE
